- Anxiety
- Depression
- Alzheimer's Disease
- Weight Loss
- Heart Disease
- Cancer
- Asthma
Trial Phase
Trial Status
Paid Participation
Clear All
71 Hepatitis C Trials Near You
Power is an online platform that helps thousands of Hepatitis C patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.
Learn More About PowerRapid Hepatitis C Treatment Access for Drug Users
Trial Details
Key Eligibility Criteria
124 Participants Needed
Epclusa for Chronic Hepatitis C
Trial Details
Key Eligibility Criteria
121 Participants Needed
Trial Details
Key Eligibility Criteria
26 Participants Needed
Transitional Care Program for HIV, Hepatitis C, and Substance Use Disorders
Trial Details
Key Eligibility Criteria
219 Participants Needed
VIR-2218 + Peginterferon Alfa-2a for Chronic Hepatitis B
Trial Details
Key Eligibility Criteria
50 Participants Needed
Trial Details
Key Eligibility Criteria
244 Participants Needed
Daplusiran/Tomligisiran + Bepirovirsen for Chronic Hepatitis B
Trial Details
Key Eligibility Criteria
280 Participants Needed
Bepirovirsen for HIV and Hepatitis B
Trial Details
Key Eligibility Criteria
150 Participants Needed
HCV Prophylaxis Strategies for Kidney Transplant Recipients
Trial Details
Key Eligibility Criteria
120 Participants Needed
Educational App for Hepatitis C
Trial Details
Key Eligibility Criteria
308 Participants Needed
Rapid HCV Test for Hepatitis C
Trial Details
Key Eligibility Criteria
200 Participants Needed
Overdose Prevention Intervention for Drug Overdose
Trial Details
Key Eligibility Criteria
285 Participants Needed
Imdusiran for Chronic Hepatitis B
Trial Details
Key Eligibility Criteria
10 Participants Needed
AHB-137 Injection for Chronic Hepatitis B
Trial Details
Key Eligibility Criteria
90 Participants Needed
Anakinra for Heart Failure
Trial Details
Key Eligibility Criteria
20 Participants Needed
Heplisav-B for Liver Cirrhosis
Trial Details
Key Eligibility Criteria
200 Participants Needed
Integrated AUD Treatment for Alcoholic Hepatitis
Trial Details
Key Eligibility Criteria
200 Participants Needed
Care Coordination with Peer Support for Hepatitis C
Trial Details
Key Eligibility Criteria
80 Participants Needed
Digital Community for HIV & Hepatitis C Prevention
Trial Details
Key Eligibility Criteria
459 Participants Needed
JNJ-73763989 + Antivirals for Hepatitis B and D Co-Infection
Trial Details
Key Eligibility Criteria
52 Participants Needed
Why Other Patients Applied
"As a healthy volunteer, I like to participate in as many trials as I'm able to. It's a good way to help research and earn money."
"I was diagnosed with stage 4 pancreatic cancer three months ago, metastatic to my liver, and I have been receiving and responding well to chemotherapy. My blood work revealed that my tumor markers have gone from 2600 in the beginning to 173 as of now, even with the delay in treatment, they are not going up. CT Scans reveal they have been shrinking as well. However, chemo is seriously deteriorating my body. I have 4 more treatments to go in this 12 treatment cycle. I am just interested in learning about my other options, if any are available to me."
"I've been struggling with ADHD and anxiety since I was 9 years old. I'm currently 30. I really don't like how numb the medications make me feel. And especially now, that I've lost my grandma and my aunt 8 days apart, my anxiety has been even worse. So I'm trying to find something new."
"I've tried several different SSRIs over the past 23 years with no luck. Some of these new treatments seem interesting... haven't tried anything like them before. I really hope that one could work."
"I changed my diet in 2020 and I’ve lost 95 pounds from my highest weight (283). I am 5’3”, female, and now 188. I still have a 33 BMI. I've been doing research on alternative approaches to continue my progress, which brought me here to consider clinical trials."
Tobevibart + Elebsiran for Hepatitis
Trial Details
Key Eligibility Criteria
120 Participants Needed
Education + Antiviral Therapy for Hepatitis C
Trial Details
Key Eligibility Criteria
200 Participants Needed
Patient Navigation & Counseling for HIV Prevention and Hepatitis C
Trial Details
Key Eligibility Criteria
446 Participants Needed
Ganchero Intervention for Drug Overdose and Infection Risk
Trial Details
Key Eligibility Criteria
69 Participants Needed
HepB mAb19 for Chronic Hepatitis B
Trial Details
Key Eligibility Criteria
37 Participants Needed
Siplizumab for Autoimmune Liver Disease
Trial Details
Key Eligibility Criteria
8 Participants Needed
HIV/HCV Testing for Substance Use Disorder
Trial Details
Key Eligibility Criteria
51 Participants Needed
Health Communication for HIV/AIDS and Hepatitis C
Trial Details
Key Eligibility Criteria
2000 Participants Needed
SCG101 for Liver Cancer
Trial Details
Key Eligibility Criteria
46 Participants Needed
Vitamin A for Vaccine Response Enhancement
Trial Details
Key Eligibility Criteria
22 Participants Needed
Know someone looking for new options?
Spread the word
Learn More About Power
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.
Frequently Asked Questions
How much do Hepatitis C clinical trials pay?
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.
How do Hepatitis C clinical trials work?
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across Hepatitis C trials 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length for Hepatitis C is 12 months.
How do I participate in a study as a "healthy volunteer"?
Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.
What does the "phase" of a clinical trial mean?
The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.
Do I need to be insured to participate in a Hepatitis C medical study?
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
What are the newest Hepatitis C clinical trials?
Most recently, we added Integrated Care for Opioid Use Disorder, Rapid HCV Test for Hepatitis C and Sofosbuvir/Velpatasvir for Hepatitis C to the Power online platform.